信澳健康中国混合A(003291)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
80,170,331.77 |
133,400,439.13 |
74,655,544.32 |
-165,962,365.81 |
| 利息合计 |
95,315.04 |
272,999.91 |
171,744.27 |
1,664,690.51 |
| 其中:存款利息收入 |
95,315.04 |
265,965.95 |
164,710.31 |
661,981.87 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
7,033.96 |
7,033.96 |
1,002,708.64 |
| 投资收益合计 |
55,434,294.27 |
120,391,198.45 |
-10,715,781.08 |
-219,483,169.72 |
| 其中:股票投资收益 |
53,880,592.00 |
112,650,468.17 |
-17,208,563.51 |
-236,090,777.85 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
1,553,702.27 |
7,740,730.28 |
6,492,782.43 |
16,607,608.13 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
24,469,300.18 |
12,415,228.32 |
85,049,278.73 |
51,215,312.32 |
| 其他收入 |
171,422.28 |
321,012.45 |
150,302.40 |
640,801.08 |
| 费用 |
3,711,073.44 |
10,502,208.94 |
5,525,439.22 |
19,270,810.93 |
| 管理人报酬 |
2,768,743.10 |
7,857,235.87 |
4,116,436.70 |
14,275,611.27 |
| 基金托管费 |
461,457.16 |
1,309,539.34 |
686,072.78 |
2,379,268.45 |
| 销售服务费 |
372,458.03 |
1,107,303.73 |
609,490.19 |
2,387,761.21 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
108,415.15 |
228,130.00 |
113,439.55 |
228,170.00 |
| 利润总额 |
76,459,258.33 |
122,898,230.19 |
69,130,105.10 |
-185,233,176.74 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年